Baricitinib Lipid-Based Nanosystems as a Topical Alternative for Atopic Dermatitis Treatment
Atopic dermatitis (AD) is a chronic autoimmune inflammatory skin disorder which causes a significant clinical problem due to its prevalence. The ongoing treatment for AD is aimed at improving the patient's quality of life. Additionally, glucocorticoids or immunosuppressants are being used in sy...
Saved in:
Main Authors: | Núria Garrós (Author), Paola Bustos-Salgados (Author), Òscar Domènech (Author), María José Rodríguez-Lagunas (Author), Negar Beirampour (Author), Roya Mohammadi-Meyabadi (Author), Mireia Mallandrich (Author), Ana C. Calpena (Author), Helena Colom (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baricitinib Liposomes as a New Approach for the Treatment of Sjögren's Syndrome
by: Núria Garrós, et al.
Published: (2022) -
Formulation of Polymeric Nanoparticles Loading Baricitinib as a Topical Approach in Ocular Application
by: Negar Beirampour, et al.
Published: (2024) -
Assessing the Solubility of Baricitinib and Drug Uptake in Different Tissues Using Absorption and Fluorescence Spectroscopies
by: Roya Mohammadi-Meyabadi, et al.
Published: (2022) -
Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis
by: Roya Mohammadi-Meyabadi, et al.
Published: (2024) -
Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
by: Danielle Rogner, et al.
Published: (2022)